Journal
FEBS JOURNAL
Volume 275, Issue 23, Pages 5767-5773Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1742-4658.2008.06709.x
Keywords
ceramide; gene; glucocerebrosidase; Lewy body; loci; mutation; pathogenesis; pathway; risk factor; susceptibility
Categories
Funding
- National Institute on Aging
- National Institutes of Health
- Department of Health and Human Services [Z01-AG 000957-05]
- Portuguese FCT [SFRH/BD/29647/2006]
- Medical Research Council [G0701075] Funding Source: researchfish
- Fundação para a Ciência e a Tecnologia [SFRH/BD/29647/2006] Funding Source: FCT
- MRC [G0701075] Funding Source: UKRI
Ask authors/readers for more resources
Heterozygous loss-of-function mutations at the glucosecerebrosidase locus have recently been shown to be a potent risk factor for Lewy body disease. Based on this observation, we have re-evaluated the likelihood that the different PARK loci (defined using clinical criteria for disease) may be misleading attempts to find common pathways to pathogenesis. Rather, we suggest, grouping the different loci which lead to different Lewy body disease may be more revealing. Doing this, we suggest that several of the genes involved in disparate Lewy body diseases impinge on ceramide metabolism and we suggest that this may be a common theme for pathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available